Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-22 5:21 pm Purchase | 2023-02-22 | 13D | Lifeward Ltd. LFWD | Lind Global Fund II LP | 1,337,431 15.100% | 3,666 (+0.27%) | Filing History |
| 2023-02-21 4:52 pm Purchase | 2023-02-16 | 13G | Constellation Pharmaceuticals, Inc. CNST | Lind Global Fund II LP | 1,505,000 9.900% | 1,505,000 (New Position) | Filing History |
| 2023-02-21 4:51 pm Purchase | 2023-02-17 | 13G | Constellation Pharmaceuticals, Inc. CNST | Lind Global Fund II LP | 1,018,518 6.200% | 1,018,518 (New Position) | Filing History |
| 2023-02-21 4:49 pm Purchase | 2023-02-13 | 13G | Revelation Biosciences, Inc. REVB | Lind Global Fund II LP | 130 5.200% | 130 (New Position) | Filing History |
| 2023-02-14 4:53 pm Purchase | 2023-02-10 | 13G | Sintx Technologies, Inc. SINT | Lind Global Fund II LP | 1,288 9.900% | 1,288 (New Position) | Filing History |
| 2023-02-13 4:38 pm Purchase | 2022-12-31 | 13G | Kiora Pharmaceuticals, Inc. KPRX | Lind Global Fund II LP | 17,008 7.900% | 17,008 (New Position) | Filing History |
| 2023-02-13 4:37 pm Purchase | 2022-12-31 | 13G | Nuwellis, Inc. NUWE | Lind Global Fund II LP | 37 0.200% | 37 (New Position) | Filing History |
| 2023-02-13 4:36 pm Sale | 2022-12-31 | 13G | Grom Social Enterprises, Inc. GROM | Lind Global Fund II LP | 12,004 9.900% | -454 (-3.64%) | Filing History |
| 2023-02-13 4:35 pm Sale | 2022-12-31 | 13G | Bragg Gaming Group Inc. BRAG | Lind Global Fund II LP | 979,048 4.400% | -190,810 (-16.31%) | Filing History |
| 2023-02-13 4:34 pm Purchase | 2022-12-31 | 13G | Palisade Bio, Inc. PALI | Lind Global Fund II LP | 2,066 1.400% | 2,066 (New Position) | Filing History |
| 2023-02-13 4:34 pm Purchase | 2022-12-31 | 13G | Performance Shipping Inc. PSHG | Lind Global Fund II LP | 227,000 4.990% | 227,000 (New Position) | Filing History |
| 2023-02-13 4:33 pm Purchase | 2022-12-31 | 13G | Agile Therapeutics, Inc. AGRX | Lind Global Fund II LP | 89,195 9.900% | 24,191 (+37.21%) | Filing History |
| 2023-02-13 4:32 pm Purchase | 2022-12-31 | 13G | Staffing 360 Solutions, Inc. STAF | Lind Global Fund II LP | 9,509 3.600% | 9,509 (New Position) | Filing History |
| 2023-02-13 4:31 pm Purchase | 2022-12-31 | 13G | Energy Focus, Inc. EFOI | Lind Global Fund II LP | 117,751 7.900% | 3,142 (+2.74%) | Filing History |
| 2023-02-13 4:30 pm Sale | 2022-12-31 | 13G | Vallon Pharmaceuticals, Inc. VLON | Lind Global Fund II LP | 250 0.100% | -35,900 (-99.31%) | Filing History |
| 2023-02-13 4:30 pm Purchase | 2022-12-31 | 13G | Salarius Pharmaceuticals, Inc. SLRX | Lind Global Fund II LP | 742 3.800% | 742 (New Position) | Filing History |
| 2023-02-13 4:29 pm Purchase | 2022-12-31 | 13G | Kintara Therapeutics, Inc. KTRA | Lind Global Fund II LP | 2,156 0.100% | 2,156 (New Position) | Filing History |
| 2023-02-13 4:28 pm Unchanged | 2022-12-31 | 13G | China SXT Pharmaceuticals, Inc. SXTC | Lind Global Fund II LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2023-02-13 4:28 pm Purchase | 2022-12-31 | 13G | Lifeward Ltd. LFWD | Lind Global Fund II LP | 1,333,765 15.100% | 299,746 (+28.99%) | Filing History |
| 2023-02-13 4:27 pm Purchase | 2022-12-31 | 13G | CEA Industries Inc. Common Stock BNC | Lind Global Fund II LP | 46,242 7.000% | 12,908 (+38.72%) | Filing History |